Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
6
6 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- HTD1801Berberine UrsodeoxycholatePhase 34 trials
Shenzhen HighTide Biopharmaceutical Ltd. · T2DM (Type 2 Diabetes Mellitus), Nonalcoholic Steatohepatitis (NASH), Type 2 Diabetes
- INS018_055Phase 32 trials
InSilico Medicine Hong Kong Limited · Idiopathic Pulmonary Fibrosis (IPF), Idiopathic Pulmonary Fibrosis
- EI-001Phase 21 trial
Elixiron Immunotherapeutics (Hong Kong) Ltd. · Non-segmental Vitiligo
- GarutadustatISM5411Phase 21 trial
InSilico Medicine Hong Kong Limited · Ulcerative Colitis
- ISM3412Phase 21 trial
InSilico Medicine Hong Kong Limited · Locally Advanced/Metastatic Solid Tumors
- ISM6331Phase 21 trial
InSilico Medicine Hong Kong Limited · Malignant Mesothelioma, Metastatic Malignant Solid Tumor, Advanced Solid Tumor
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.